Macquarie Group LTD Kiniksa Pharmaceuticals, Ltd. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $3,250 - $4,465	-333 Reduced 7.65%	4,020 $56,000
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $45,787 - $65,244	4,020 Added 1207.21%	4,353 $50,000
Q1 2021 May 14, 2021	SELL	$16.68 - $23.97 $2,635 - $3,787	-158 Reduced 32.18%	333 $6,000
Q2 2020 Aug 11, 2020	BUY	$15.08 - $26.0 $7,404 - $12,766	491 New	491 $13,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.